13 December 2021 - Today, the Regulation on Health Technology Assessment, a deliverable of the EU Pharmaceutical Strategy, has been adopted.
The new rules will allow vital and innovative health technologies - such as innovative medicines, certain medical devices, medical equipment and prevention and treatment methods - to be more widely available.
The Regulation will also ensure the efficient use of resources, strengthen the quality of health technology assessment across the EU, and save national health technology assessment bodies and industry from duplicating their efforts, reassure business and ensure the long-term sustainability of EU HTA co-operation.